Daily Archives: March 21, 2018


lixisenatide + insulin glargine (Soliqua)

Generic Name: lixisenatide + insulin glargine Brand Name: Soliqua Manufacturer: sanofi-aventis Canada Inc. Indications: Diabetes mellitus, Type 2 Manufacturer Requested Reimbursement Criteria1: ​As per indication. Submission Type: New Combination Project Status: Pending Call For Patient Input: March 21, 2018 Patient Input Closed: May 10, 2018 Anticipated Date: April 19, 2018 […]